Bank of New York Mellon Corp - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$65,357,000
+40.5%
1,827,186
+2.2%
0.02%
+30.8%
Q3 2014$46,508,000
-50.9%
1,788,725
-37.5%
0.01%0.0%
Q2 2014$94,650,000
+105.4%
2,863,824
+86.0%
0.01%0.0%
Q1 2014$46,086,000
-15.3%
1,539,801
-14.1%
0.01%
-13.3%
Q4 2013$54,400,000
-49.5%
1,791,814
-47.0%
0.02%
-6.2%
Q3 2013$107,644,000
+429.9%
3,383,970
+151.7%
0.02%
+166.7%
Q2 2013$20,314,0001,344,4510.01%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Century Capital Management, LLC 97,360$3,483,0000.10%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 387,600$17,799,0000.02%
View complete list of NPS PHARMACEUTICALS INC shareholders